National Health Determination under paragraph 98C(1)(b) Amendment 2018 (No. 2) (PB 13 of 2018) (Cth)

PB 13 of 2018

National Health Determination under paragraph 98C(1)(b) Amendment 2018
(No. 2)

_____________________________________________________________________

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.

Dated         26 February 2018

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

1       Name of Instrument

(1)This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2018 (No. 2).

(2)This Instrument may also be cited as PB 13 of 2018.

2       Commencement

This instrument commences on 1 March 2018.

3       Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).

Schedule 1            Amendments

1. Schedule 4, entry for Risedronic Acid and Calcium

omit:

Pack containing 4 enteric coated tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate)